HC Wainwright Forecasts Weaker Earnings for Inozyme Pharma
Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) – Research analysts at HC Wainwright reduced their Q1 2025 earnings per share (EPS) estimates for shares of Inozyme Pharma in a report released on Tuesday, March 11th. HC Wainwright analyst E. White now expects that the company will post earnings of ($0.44) per share for the quarter, […]
Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) – Research analysts at HC Wainwright reduced their Q1 2025 earnings per share (EPS) estimates for shares of Inozyme Pharma in a report released on Tuesday, March 11th. HC Wainwright analyst E. White now expects that the company will post earnings of ($0.44) per share for the quarter, […]
